The 12 closest competitors and alternatives to Chiesi Farmaceutici among pharmaceuticals companies — ranked by similarity to what Chiesi Farmaceutici actually does, not by market-cap band.
Subscribe to see Chiesi Farmaceutici’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Chiesi Farmaceutici is a global biopharmaceutical group that researches, develops, and commercializes therapeutic solutions for patients. The company focuses primarily on respiratory health, rare diseases, and specialty care.
Chiesi Farmaceutici is a pharmaceuticals company headquartered in Italy. Xcout tracks 5 named people at Chiesi Farmaceutici, including Alessandro Chiesi (Vicepresidente).
Ranked by semantic similarity — how close each company is to Chiesi Farmaceutici by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar pharmaceuticals company
Recordati is a global pharmaceutical company that develops and commercializes medicines for both common and rare diseases. It serves patients across approximately 150 countries through its specialty, primary care, and rare diseases operations.
Similar pharmaceuticals company
Ferring Pharmaceuticals is a specialty biopharmaceutical company that develops and delivers treatments in reproductive medicine, maternal health, gastroenterology, urology, and uro-oncology. The company focuses on helping people build families, supporting maternal and infant health, and providing therapeutic solutions for various medical conditions worldwide.
Similar pharmaceuticals company
CSL Vifor is part of the global biotechnology company CSL, focusing on the development and delivery of medical treatments for patients. Specifically, the company specializes in addressing therapeutic areas such as iron deficiency and nephrology.
Similar pharmaceuticals company
Novo Nordisk is a global healthcare company that researches, develops, manufactures, and markets pharmaceutical products. It primarily provides treatments and medical solutions for chronic conditions such as diabetes, obesity, and rare blood and endocrine disorders to serve patients and healthcare professionals.
Similar pharmaceuticals company
Verona Pharma plc focuses on innovative respiratory treatments and is headquartered in London, UK, alongside offices in the United States.
Similar pharmaceuticals company
Menarini is a global pharmaceutical company headquartered in Florence, Italy. It has three divisions: Menarini Ricerche, Menarini Biotech, and Menarini Diagnostics, and focuses on developing pharmacological products.
Similar pharmaceuticals company
Fidia Farmaceutici S.p.A. is an international pharmaceutical company that researches, develops, and manufactures therapeutic solutions focusing on joint care, skin care, eye care, and regenerative medicine. The company utilizes hyaluronic acid technologies to provide healthcare products and treatments for patients globally.
Similar pharmaceuticals company
Almirall is a Spanish pharmaceutical company headquartered in Barcelona, focused primarily on researching, developing, and commercializing prescription medicines for dermatological diseases, with additional activities in areas such as respiratory health. It serves patients and healthcare professionals through products marketed in Spain and international markets.
Similar pharmaceuticals company
Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.
Similar pharmaceuticals company
Grünenthal is a global pharmaceutical company that researches, develops, and commercializes innovative treatments and medicines with a primary focus on pain management and related diseases. Operating as a science-based business, the company serves patients worldwide by delivering therapies for conditions such as chronic pain, rare diseases, and neurobiological indications.
Similar pharmaceuticals company
Pharming Group N.V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets. Its primary commercialized product is Ruconest, a recombinant human C1 esterase inhibitor utilized for the acute treatment of hereditary angioedema. Pharming's development pipeline also includes rhC1INH, which is being investigated for conditions such as pre-eclampsia, acute kidney injury, and COVID-19. Additionally, the company is developing leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) inhibitor designed for patients with activated PI3K delta syndrome, as well as an alpha-glucosidase therapy targeting Pompe and Fabry diseases. The company has established significant collaborations, including a development and licensing agreement with Novartis. It also maintains a strategic partnership with Orchard Therapeutics plc for the research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy intended for hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.
Similar pharmaceuticals company
GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally. Its research and development efforts focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Chiesi Farmaceuticiand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →